Venetoclax duration outcomes analysis in MDS/AML within a community hospital

Authors

Michael Williams, Advocate Health - MidwestFollow
Ankoor Biswas, Advocate Health - MidwestFollow
Rachel R. Johnson, Advocate Health - MidwestFollow
Zaid Al-Kadhimi
Sherjeel Sana, Advocate Health - MidwestFollow
Stephen Charles Medlin
Zartash Gul

Recommended Citation

Williams M, Biswas A, Johnson RR, et al. Venetoclax duration outcomes analysis in MDS/AML within a community hospital. Journal of Clinical Oncology. 2025;43(16_suppl):e18511-e18511. doi:10.1200/JCO.2025.43.16_suppl.e18511

Type

Abstract